Research / GBR / Fundamental state Inspectable configuration
State dimensions Filing 0001010549-21-000088 General Corporate
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
96.15% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-79.20% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-253.85% · CORE · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 18 states Self-history eligible
Mar 31, 2021 0/3 normalized Level 3 Mar 31, 2022 0/3 normalized Level 3 Jun 30, 2022 0/3 normalized Level 3 Dec 31, 2022 2/3 normalized Level 3 Mar 31, 2023 2/3 normalized Level 3 Jun 30, 2023 2/3 normalized Level 3 Sep 30, 2023 2/3 normalized Level 3 Dec 31, 2023 2/4 normalized Level 3 Mar 31, 2024 3/3 normalized Level 3 Jun 30, 2024 3/3 normalized Level 3 Sep 30, 2024 3/3 normalized Level 3 Dec 31, 2024 3/4 normalized Level 3 Mar 31, 2025 3/3 normalized Level 3 Jun 30, 2025 3/3 normalized Level 3 Sep 30, 2025 3/3 normalized Level 3 Dec 31, 2025 3/3 normalized Level 3 Mar 31, 2026 3/3 normalized Level 3 Jun 30, 2026 3/3 normalized Level 4 Period transition
What moved in the state? Cash Generation Increased
Previous 13.60%
Current 96.15%
Delta 82.55% Profitability Decreased
Previous -125.60%
Current -253.85%
Delta -128.25% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.